Analysis
Identification and Expression of GFAP, YKL-40 and RBP4 in Serum as Noninvasive Biomarkers with Diagnostic and Prognostic Value for Detecting and Monitoring Glioma Patients [Volume 1, Issue 1, 2019, Page 10-19]
B
Brain
Recent Developments of Diagnostic Criteria in Multiple Sclerosis [Volume 1, Issue 1, 2019, Page 20-28]
C
Cisplatin
Amelioration and Prognostic Significance of the Urine/Plasma Protein Creatinine Ratio Levels (uCr/pCr) as Predictive Biomarkers and its Change Patterns in Early Diagnosis of Cisplatin-Induced Nephrotoxicity of Solid Tumors [Volume 1, Issue 1, 2019, Page 1-9]
Creatinine
Amelioration and Prognostic Significance of the Urine/Plasma Protein Creatinine Ratio Levels (uCr/pCr) as Predictive Biomarkers and its Change Patterns in Early Diagnosis of Cisplatin-Induced Nephrotoxicity of Solid Tumors [Volume 1, Issue 1, 2019, Page 1-9]
D
Demographic
Investigation of Health Status with Psychological Aspects [Volume 1, Issue 1, 2019, Page 29-34]
Diagnosis
Recent Developments of Diagnostic Criteria in Multiple Sclerosis [Volume 1, Issue 1, 2019, Page 20-28]
E
Expression
Identification and Expression of GFAP, YKL-40 and RBP4 in Serum as Noninvasive Biomarkers with Diagnostic and Prognostic Value for Detecting and Monitoring Glioma Patients [Volume 1, Issue 1, 2019, Page 10-19]
G
General Health
Investigation of Health Status with Psychological Aspects [Volume 1, Issue 1, 2019, Page 29-34]
Glioma
Identification and Expression of GFAP, YKL-40 and RBP4 in Serum as Noninvasive Biomarkers with Diagnostic and Prognostic Value for Detecting and Monitoring Glioma Patients [Volume 1, Issue 1, 2019, Page 10-19]
I
Imaging
Recent Developments of Diagnostic Criteria in Multiple Sclerosis [Volume 1, Issue 1, 2019, Page 20-28]
Injury
Amelioration and Prognostic Significance of the Urine/Plasma Protein Creatinine Ratio Levels (uCr/pCr) as Predictive Biomarkers and its Change Patterns in Early Diagnosis of Cisplatin-Induced Nephrotoxicity of Solid Tumors [Volume 1, Issue 1, 2019, Page 1-9]
K
Kidney
Amelioration and Prognostic Significance of the Urine/Plasma Protein Creatinine Ratio Levels (uCr/pCr) as Predictive Biomarkers and its Change Patterns in Early Diagnosis of Cisplatin-Induced Nephrotoxicity of Solid Tumors [Volume 1, Issue 1, 2019, Page 1-9]
M
Magnetic resonance imaging
Recent Developments of Diagnostic Criteria in Multiple Sclerosis [Volume 1, Issue 1, 2019, Page 20-28]
Marker
Identification and Expression of GFAP, YKL-40 and RBP4 in Serum as Noninvasive Biomarkers with Diagnostic and Prognostic Value for Detecting and Monitoring Glioma Patients [Volume 1, Issue 1, 2019, Page 10-19]
Medical Staff
Investigation of Health Status with Psychological Aspects [Volume 1, Issue 1, 2019, Page 29-34]
Mental Disorders
Investigation of Health Status with Psychological Aspects [Volume 1, Issue 1, 2019, Page 29-34]
Multiple sclerosis
Recent Developments of Diagnostic Criteria in Multiple Sclerosis [Volume 1, Issue 1, 2019, Page 20-28]
N
Neuropathology
Recent Developments of Diagnostic Criteria in Multiple Sclerosis [Volume 1, Issue 1, 2019, Page 20-28]
P
PCR
Identification and Expression of GFAP, YKL-40 and RBP4 in Serum as Noninvasive Biomarkers with Diagnostic and Prognostic Value for Detecting and Monitoring Glioma Patients [Volume 1, Issue 1, 2019, Page 10-19]
S
Serum
Amelioration and Prognostic Significance of the Urine/Plasma Protein Creatinine Ratio Levels (uCr/pCr) as Predictive Biomarkers and its Change Patterns in Early Diagnosis of Cisplatin-Induced Nephrotoxicity of Solid Tumors [Volume 1, Issue 1, 2019, Page 1-9]
Spinal
Recent Developments of Diagnostic Criteria in Multiple Sclerosis [Volume 1, Issue 1, 2019, Page 20-28]
U
Urinary
Amelioration and Prognostic Significance of the Urine/Plasma Protein Creatinine Ratio Levels (uCr/pCr) as Predictive Biomarkers and its Change Patterns in Early Diagnosis of Cisplatin-Induced Nephrotoxicity of Solid Tumors [Volume 1, Issue 1, 2019, Page 1-9]